Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin)

American Journal of Tropical Medicine and Hygiene

Volumn 58, Issue 4, 1998, Pages 448-453

  Vexenat, J A ^a   Olliaro, P L ^b   De Castro, J A Fonseca ^c   Cavalcante, R ^c   Furtado Campos, J H ^c   Tavares, J P ^a,d   Miles, M A ^a,e  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^d FUNDAÇÃO NACIONAL DE SAÚDE   (Brazil)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; PAROMOMYCIN;

ANIMAL CELL; ANIMAL PARASITOSIS; ANIMAL TISSUE; ARTICLE; BRAZIL; CONJUNCTIVITIS; DOG; DOSE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; LETHALITY; NONHUMAN; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

EID: 0031945576     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1998.58.448     Document Type: Article

References (29)

1. World Health Organization, 1990. Control of the leishmaniases. World Health Organ Tech Rep Ser: 793.
2. Shaw J, 1994. Taxonomy of the genus Leishmania: present and future trends and their implications. Mem Inst Oswaldo Cruz 89: 471-478.
3. Deane LM, Deane MP, 1962. Visceral leishmaniasis in Brazil: geographical distribution and transmission. Rev Inst Med Trop Sao Paulo 4: 198-212.
4. Lanotte G, Rioux JA, Periers J, Vollhardt Y, 1979. Ecologie des leishmanioses dans le sud de la France. 10. Les formes evolutives de la leishmaniose viscerale canine. Elaboration d' une typologie bio-clinique a finalite epidemiologique. Ann Parasitol Hum Comp 54: 277-295.
5. Alvar J, Molina R, San Andres M, Tesouro M, Nieto J, Vitutia M, Gonzalez F, San Andres MD, Boggio J, Rodrigues F, Sainz A, Escacena C, 1994. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol 88: 371-378.
6. Marsden PD, 1985. Pentavalent antimonials: old drugs for new diseases. Rev Soc Bras Med Trop 18: 187-198.
7. Olliaro P, Bryceson ADM, 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol Today 9: 323-328.
8. Grogl M, Thomason TN, Franke ED, 1992. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease. Am J Trop Med Hyg 47: 117-126.
9. Gradoni L, Maroli M, Gramiccia M, Mancianti, F, 1987. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimomal treatment. Med Vet Entomol 1: 339-342.
10. Gramiccia M, Gradoni L, Orsini S, 1992. Decreased sensitivity to antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann Trop Med Parasitol 86: 613-620.
11. Marzochi MCA, Marzochi KFB, Carvalho RW, 1994. Visceral leishmaniasis in Rio de Janeiro. Parasitol Today 10: 37-40.
12. Schillings RT, Schaffner C, 1961. Differentiation of catenulinneomycin antibiotics: identity of catenulin, paramomycin, hydroxymycin and aminosidin. Antimicrob Agents Chemother 4: 274-285.
13. Neal RA, 1968. The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasis. Ann Trop Med Parasitol 62: 54-62.
14. Neal RA, Allen S, McCoy N, Olliaro P, Croft SL, 1995. The sensitivity of Leishmania species to aminosidine. J Antimicrob Chemother 35: 577-584.
15. Chunge CN, Owate J, Pamba HO, Donno L, 1990. Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconate. Trans R Soc Trop Med Hyg 84: 221-225.
16. Scott JAD, Davidson RM, Moody AH, Grant HR, Felmingham D, Scott GMS, Olliaro P, Bryceson, ADM, 1992. Aminosidine (paramomycin) in the treatment of leishmaniasis imported into the United Kingdom. Trans R Soc Trop Med Hyg 86: 617-619.
17. Hassan M, Baat DB, Hassan K, 1995. A new breakthrough in treatment of visceral leishmaniasis in children. J Pak Med Assoc 45: 155-157.
18. Soto J, Grogl M, Berman J, Olliaro P, 1994. Limited efficacy of injectable aminosidine as single-agent therapy for Colombian cutaneous leishmanisis. Trans R Soc Trop Med Hyg 88: 695-698.
19. Thakur CP, Olliaro P, Gothoskar S, Bhowmick S, Choudhury BK, Prasad S, Kumar M, Verma BB, 1992. Treatment of visceral leishmaniasis (kala-azar) with aminosidine (=paramomycin)-antimonial combinations, a pilot study in Bihar, India. Trans R Soc Trop Med Hyg 86: 615-616.
20. Thakur CP, Bhowmick S, Dolfi L, Olliaro P, 1995. Aminosidine plus sodium stibogluconate for the treatment of Indian kalaazar: a randomized dose-finding clinical trial. Trans R Soc Trop Med Hyg 89: 219-223.
21. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson ADM, Davidson RN, 1993. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. J Infect Dis 168: 715-720.
22. Costa CHN, Pereira HF, Araujo MV, 1990. Epidemia de leishmaniose visceral no estado do Piaui, Brasil. Rev Saude Publica 24: 361-372.
23. Vexenat JA, Fonseca de Castro JA, Cavalcante R, da Silva MRP, Batista WH, Furtado Campos JH, Alves Pereira FC, Tavares JP, Miles MA, 1993. Preliminary observations on the diagnosis and transmissibility of canine visceral leishmaniasis in Teresina, N.E. Brazil. Arch Inst Past Tunis 70: 467-472.
24. Vexenat JA, Fonseca de Castro JA, Cavalcante R, Tavares JP, Silva MRB da, Batista WH, Furtado Campos JH, Howard MK, Frame I, McNerney R, Wilson S, Miles MA, 1994. Visceral leishmaniasis in Teresina, State of Piaui, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections. Mem Inst Oswaldo Cruz 89: 131-135.
25. Pugnetti G, 1988. The Macdonald Encyclopaedia of Dogs. London: Little Brown Book Company.
26. Tassi P, Ormas P, Madonna M, Carli S, Belloli C, Natale G de, Ceci L, Marcotrigiano GO, 1994. Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in the dog. Res Vet Sci 56: 144-150.
27. Fong D, Chan MM, Rodriguez R, Gately LJ, Berman JD, Grogl, M, 1994. Paromomycin resistance in Leishmania tropica: lack of correlation with mutation in the small subunit ribosomal RNA gene. Am J Trop Med Hyg 51: 758-766.
28. Belloli C, Ceci L, Carli S, Tassi P, Montessica C, De-Natale G, Marcotrigiano G, Ormas P, 1995. Disposition of antimony and aminosidine in dogs after administration separately and together; implications for therapy of leishmaniasis. Res Vet Sci 58: 123-127.
29. Poli A, Abramo F, Mancianti F, Nigro M, Pieri S, Bionda A, 1991. Renal involvement in canine leishmaniasis. A light-microscopic, immunohistochemical and electron-microscopic study. Nephron 57: 444-452.